Study shows better asthma relief from combo therapy

05/23/2007 | Forbes

New data shows AstraZeneca's combination asthma treatment Symbicort improved quality of life and satisfaction for patients better than the drug's two main ingredients do separately. Symbicort, recently approved for long-term use, is a combination of the inhaled corticosteroid budesonide and the beta agonist formoterol fumarate dehydrate.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC